Review article
Interpreting Results in 2×2 Tables: Part 9 of a Series on Evaluation of Scientific Publications
Dtsch Arztebl Int 2009; 106(48): 795-800; DOI: 10.3238/arztebl.2009.0795
| 1. | Islami F, Pourshams A, Nasrollahzadeh D, et al.: Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009; 338: b929. Doi: 10.1136/bmj.b929 MEDLINE |
| 2. | Andreetta C, Puppin, C, Minisini A, et al.: Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology 2009; 20: 265–71. MEDLINE |
| 3. | Sauerbrei W, Schumacher M: Aspekte der statistischen Evaluation neuer Prognosefaktoren: Illustration bei Studien in der Onkologie. Geburtshilfe und Frauenheilkunde 1999; 59: 483–7. |
| 4. | Fletcher RH, Fletcher SW: Klinische Epidemiologie. 2..Aufl. Bern: Huber 2007. |
| 5. | Altman DG: Practical statistics for medical research. London: Chapman and Hall 1991. |
| 6. | Campbell MJ, Machin D, Walters SJ: Medical statistics—a textbook for the health sciences. 4. Aufl. Chichester: Wiley 2007. |
| 7. | Schumacher M, Schulgen G: Methodik klinischer Studien – Methodische Grundlagen der Planung, Durchführung und Auswertung. 3. Aufl. Berlin: Springer 2008. |
| 8. | Victor A, Elsäßer A, Hommel G, Blettner M: Wie bewertet man die p-Wert-Flut – Hinweise zum Umgang mit dem multiplen Testen. 2009 (Deutsches Ärzteblatt, in press) |
| 9. | Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using „optimal“ cutpoints in the evaluation of prognostic factors. J Net Cancer Inst 1994; 86: 829–35. MEDLINE |
| 10. | Royston P, Sauerbrei W: Multivariable model-building—a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Chichester: Wiley 2008. |
| 11. | Altman DG, Matthews JNS: Interaction 1: heterogeneity of effects. BMJ 1996; 313: 486. MEDLINE |
| 12. | Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064–9. MEDLINE |
| 13. | Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM: Statistics in medicine—reporting of subgroup analyses in clinical trials. The New England Journal of Medicine 2007; 357: 2189–94. MEDLINE |
| 14. | Spriestersbach A, Gerhold-Ay A, du Prel JB, Röhrig B, Blettner M: Deskriptive Statistik. Dtsch Arztebl Int 2009; 106(36): 578–83. MEDLINE |